Use of Tumor Marker and Enzymes in Recurrence and Monitoring Response to Pre and Post Chemotherapy for Patients with Upper Gastrointestinal Carcinoma

Abstract

Aim - To analyze the level of serum Carcinoembryonic antigen (CEA) Glutathione-S-Transferase (GSTs), Lactate Dehydrogenase (LDH) and Alkaline Phosphatase (ALP) before and after different cycles of chemotherapy in reference to upper gastrointestinal cancer patients. Methods - For the study comprising total 232 cases suffering from gastrointestinal cancer (before and after different cycles of chemotherapy) were selected. All patients were clinically and histopathologically diagnosed. A total of 42 age and sex matched healthy subjects taken as control. The circulating levels of CEA, GSTs, LDH and ALP activity were assayed in the in the serum of control group and in patients with gastrointestinal cancer. Results - Mean CEA, GSTs, LDH and ALP activity in serum were significantly higher in gastrointestinal cancer patients as compared to normal control group (p<0.001). After first chemotherapy (stage II) the activity of GSTs, LDH and ALP were significantly higher but the activity of CEA was highly significantly decreased than before chemotherapy (stage I). In stage III (after second cycle of chemotherapy) activity was significantly decreased than that of stage II and the activity of CEA, GSTs, LDH and ALP was significantly decreased in stage IV (after third cycle of chemotherapy) than stage III (after second cycle of chemotherapy) and levels become normal in range. Conclusion - The study highlights serum CEA and GSTs measurement are useful marker for gastrointestinal cancer, its activity helpful to predict the response of treatment in advanced stage of cancer and recurrence of disease. Increased levels of serum LDH and ALP indicates infection or blockage or metastasized or liver damage by treatment. LDH and ALP are good prognostic marker in gastrointestinal cancer treated with chemotherapy. Increased level of ALP indicates advanced disease progression or treatment strategy. Statistically significant changes in CEA, GSTs, LDH and ALP levels during the treatment with positive response and no established disease progression during study period near about 27 months after the treatment, which indicate that GSTs and CEA are important predictive factor.

Authors and Affiliations

Ranjit S. Ambad, Nishikant Ingole, Pooja A. Sitholay

Keywords

Related Articles

Ponticulus Posticus- The “Aching” Bridge

The Ponticulus posticus is a bony bridge located in the posterior arch of the atlas. It houses the passage of the vertebral artery. Its presence has been associated with development of cervical pain, migraine and diplopi...

Clinically Role of Serum Procalcitonin and C-reactive Protein Concentration in Diabetic Foot Ulcer Infections

Aim: - Serum inflammatory markers, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cells (WBC), and procalcitonin (PCT), have been used for the diagnosis of foot infections in patients with di...

Rare Case of Post Traumatic Carotico-Juglar-Vertebral Fistula with Pseudo Aneurysm

Arteriovenous fistula (AVF) is usually seen after acute vascular injuries. An AVF with pseudo aneurysm may present soon after the vascular injury or later. Since the AVF are associated with direct shunting of blood betwe...

Necrotizing Enterocolitis’ In Premature Neonates - The Putative Role of Early Gastrointestinal Colonization

Introduction: Necrotizing enterocolitis (NEC) is a gastrointestinal emergency and a major cause of morbidity in the neonatal intensive care unit (NICU).We studied the risk factors, pattern and type of microorganisms colo...

How I Reached the Age of 65 with a Congenital Heart Disease and Atherosclerosis

At me congenital disease of heart and the got atherosclerosis. In this publication I describe what mode of a life and what diet have helped me without medical assistance and medicines to live till 65 years and not to go...

Download PDF file
  • EP ID EP449875
  • DOI -
  • Views 62
  • Downloads 0

How To Cite

Ranjit S. Ambad, Nishikant Ingole, Pooja A. Sitholay (2017). Use of Tumor Marker and Enzymes in Recurrence and Monitoring Response to Pre and Post Chemotherapy for Patients with Upper Gastrointestinal Carcinoma. International Journal of Innovative Research in Medical Science, 2(8), 1154-1163. https://europub.co.uk/articles/-A-449875